This language amendment designates $1.0 million each year from the amounts provided in the introduced budget to the Virginia Department of Health from the Commonwealth Opioid Abatement and Remediation Fund for the purchase and distribution of eight milligram naloxone nasal spray. The fund collects the Commonwealth's share of settlement payments from manufacturers, wholesalers, and retailers involved in the distribution of opioid products.